ITCH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.519600E-01
Normal-vs-Stage2
9.413600E-01
Normal-vs-Stage3
1.104810E-01
Normal-vs-Stage4
6.243400E-01
Stage1-vs-Stage2
4.958400E-01
Stage1-vs-Stage3
1.747820E-01
Stage1-vs-Stage4
1.802170E-01
Stage2-vs-Stage3
1.132370E-01
Stage2-vs-Stage4
5.128600E-01
Stage3-vs-Stage4
5.258300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.633200E-01
Normal-vs-AfricanAmerican
6.417400E-01
Normal-vs-Asian
6.015400E-01
Caucasian-vs-AfricanAmerican
2.291400E-01
Caucasian-vs-Asian
4.012600E-01
AfricanAmerican-vs-Asian
2.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.369000E-01
Normal-vs-Female
8.586000E-01
Male-vs-Female
7.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.691200E-01
Normal-vs-Age(41-60Yrs)
6.193400E-01
Normal-vs-Age(61-80Yrs)
6.861000E-01
Normal-vs-Age(81-100Yrs)
5.801200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.360800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.396000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.826200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.483360E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.406200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.817200E-01
Normal-vs-Daily Drinker
5.654400E-01
Normal-vs-Weekly Drinker
5.512600E-01
Normal-vs-Occasional Drinker
6.140800E-01
Normal-vs-Social Drinker
8.591400E-01
Non Drinker-vs-Daily Drinker
9.107000E-01
Non Drinker-vs-Weekly Drinker
9.519200E-01
Non Drinker-vs-Occasional Drinker
3.816000E-02
Non Drinker-vs-Social Drinker
1.774390E-01
Daily Drinker-vs-Weekly Drinker
8.777200E-01
Daily Drinker-vs-Occasional Drinker
4.541700E-02
Daily Drinker-vs-Social Drinker
1.835570E-01
Weekly Drinker-vs-Occasional Drinker
7.110000E-02
Weekly Drinker-vs-Social Drinker
2.439600E-01
Occasional Drinker-vs-Social Drinker
6.007800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.739200E-01
Normal-vs-Grade 2
6.588400E-02
Normal-vs-Grade 3
5.423800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.806200E-01
Grade 1-vs-Grade 3
8.099800E-02
Grade 1-vs-Grade 4
2.739200E-01
Grade 2-vs-Grade 3
2.763800E-02
Grade 2-vs-Grade 4
6.588400E-02
Grade 3-vs-Grade 4
5.423800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.653000E-01
Normal-vs-NonDiabetic
8.727000E-01
Diabetic-vs-NonDiabetic
1.367390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.915400E-01
Normal-vs-NoPancreatitis
8.202600E-01
Pancreatitis-vs-NoPancreatitis
5.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.094200E-01
Normal-vs-N1
9.422800E-01
N0-vs-N1
5.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.307600E-01
Normal-vs-TP53-NonMutant
8.241000E-01
TP53-Mutant-vs-TP53-NonMutant
1.900040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
